OVERT PRIMARY MYELOFIBROSIS
Clinical trials for OVERT PRIMARY MYELOFIBROSIS explained in plain language.
Never miss a new study
Get alerted when new OVERT PRIMARY MYELOFIBROSIS trials appear
Sign up with your email to follow new studies for OVERT PRIMARY MYELOFIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for Hard-to-Treat leukemia: triple drug combo shows promise
Disease control OngoingThis study tests a new combination of three drugs (azacitidine, venetoclax, and pevonedistat) in adults with a difficult-to-treat form of acute myeloid leukemia (AML). The goal is to find the best dose and see how well the drugs work together to control the cancer. About 40 parti…
Matched conditions: OVERT PRIMARY MYELOFIBROSIS
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 11, 2026 12:09 UTC
-
Blood cancer patients' immune system may hold clues to severe COVID-19
Knowledge-focused OngoingThis study examines whether people with certain blood cancers (myeloproliferative neoplasms) have autoantibodies that block a key immune protein called type I interferon. These autoantibodies may increase the risk of severe COVID-19. Researchers will test blood samples from 219 p…
Matched conditions: OVERT PRIMARY MYELOFIBROSIS
Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia • Aim: Knowledge-focused
Last updated Jun 16, 2026 12:55 UTC